Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Folfox protocol × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 118 Colonic Neoplasms 52 Rectal Neoplasms 46 Carcinoma, Hepatocellular 26 Neoplasm Metastasis 22 Stomach Neoplasms 20 Neoplasms 10 Pancreatic Neoplasms 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 7 Liver Neoplasms 6 Esophageal Neoplasms 6 Biliary Tract Neoplasms 5 Recurrence 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 3 Digestive System Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma 3 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Neoplastic Cells, Circulating 2 Gastrointestinal Diseases 2 Gallbladder Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Unresectable Metastatic Colorectal Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Prostatic Neoplasms 1

Interventions

Trastuzumab 6 Carboplatin 6 Docetaxel 5 Paclitaxel 4 Oxaliplatin 4 Fluorouracil 4 Cytarabine 4 Cyclophosphamide 4 Azacitidine 4 pertuzumab 3 pembrolizumab 3 Radiotherapy 3 Observation 3 Epirubicin 3 Endoscopy 3 Cisplatin 3 Chemoradiotherapy 3 Capecitabine 3 venetoclax 2 sargramostim 2 olaparib 2 durvalumab 2 cc-486 2 Surgical Procedures, Operative 2 Standard of Care 2 Pemetrexed 2 Neoadjuvant Therapy 2 Monatide (IMS 3015) 2 Metformin 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡